Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.18 INR | +0.82% |
|
-2.72% | -17.44% |
Income Statement Evolution (Annual data)
Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 428.7 | 541.2 | 657.7 | 707 |
EBITDA 1 | 62.34 | 80.35 | 113.4 | 137.7 |
EBIT 1 | 38.11 | 51.23 | 79.96 | 98.99 |
Operating Margin | 8.89% | 9.47% | 12.16% | 14% |
Earnings before Tax (EBT) 1 | 35.74 | 47.74 | 77.17 | 108.9 |
Net income 1 | 26.28 | 35.34 | 57.28 | 80.15 |
Net margin | 6.13% | 6.53% | 8.71% | 11.34% |
EPS 2 | 3.505 | 4.714 | 7.641 | 7.575 |
Free Cash Flow | - | 6.441 | -116.3 | -261.9 |
FCF margin | - | 1.19% | -17.68% | -37.05% |
FCF Conversion (EBITDA) | - | 8.02% | - | - |
FCF Conversion (Net income) | - | 18.22% | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 3/23/23 | 3/23/23 | 3/23/23 | 6/27/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 33.6 | 3.82 | - | 86.8 |
Net Cash position 1 | - | - | 20.9 | - |
Leverage (Debt/EBITDA) | 0.5397 x | 0.0475 x | - | 0.6304 x |
Free Cash Flow | - | 6.44 | -116 | -262 |
ROE (net income / shareholders' equity) | - | 23.4% | 29% | 24.9% |
ROA (Net income/ Total Assets) | - | 9.86% | 10% | 7.93% |
Assets 1 | - | 358.4 | 573.1 | 1,011 |
Book Value Per Share 2 | 17.80 | 22.50 | 30.20 | 28.90 |
Cash Flow per Share 2 | 2.770 | 9.010 | 18.30 | 5.880 |
Capex 1 | 70.6 | 83.6 | 195 | 201 |
Capex / Sales | 16.47% | 15.45% | 29.68% | 28.49% |
Announcement Date | 3/23/23 | 3/23/23 | 3/23/23 | 6/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-17.44% | 16.39M | |
-33.38% | 13.43B | |
+5.31% | 11.95B | |
-4.50% | 11.66B | |
+13.14% | 11.08B | |
+30.61% | 8.61B | |
+24.64% | 7.63B | |
+8.05% | 6.45B | |
+16.63% | 4.39B | |
-7.45% | 4.11B |
- Stock Market
- Equities
- 543943 Stock
- Financials Asarfi Hospital Limited